1887

Abstract

Introduction:

Peritonitis is a severe complication of peritoneal dialysis (PD) due to associated morbidity and mortality. Although is mostly considered as a contaminant, its role as a causative agent in a few cases of PD peritonitis has been documented. Peritonitis due to . has been associated with high rates of catheter removal and resistance to beta‐lactam antibiotics.

Case presentation:

A case of relapsing peritonitis caused by in a 69‐year‐old man with end‐stage renal disease on continuous ambulatory PD for 3 years is described. was recovered from the patient’s peritoneal fluid and was identified by phenotypic and molecular methods. The patient was treated, according to the susceptibility test, with tobramycin for 14 days. Cultures became sterile and the patient was discharged from hospital. Three days after discharge, the patient reported recurrence of abdominal pain and a new antibiotic regimen based on the previous culture results was initiated consisting of vancomycin and ciprofloxacin. The presence of in the peritoneal fluid was confirmed, whereas repeated cultures for the next 15 days were positive. All isolates produced biofilm. On day 16, the PD catheter was removed and the patient was transferred to haemodialysis. A review of previously reported cases is also presented.

Conclusion:

Since peritonitis is the most common cause of transition to haemodialysis, isolation of from PD patients, even though rare, should not be considered as a contaminant. An appropriate antibiotic regimen and, whenever necessary, catheter removal should be applied.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.003400
2014-12-01
2019-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/1/4/jmmcr003400.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.003400&mimeType=html&fmt=ahah

References

  1. Al Hilali N. , Nampoory M.R.N. , Johny K.V. , Chugh T.D. . ( 1997; ). Bacillus cereus peritonitis in a chronic peritoneal dialysis patient. . Perit Dial Int 17:, 514–515.
    [Google Scholar]
  2. Al‐Wali W. , Baillod R. , Hamilton‐Miller J.M. , Brumfitt W. . ( 1990; ). Detective work in continuous ambulatory peritoneal dialysis. . J Infect 20:, 151–154.[CrossRef]
    [Google Scholar]
  3. Auger S. , Ramarao N. , Faille C. , Fouet A. , Aymerich S. , Gohar M. . ( 2009; ). Biofilm formation and cell surface properties among pathogenic and non‐pathogenic strains of the Bacillus cereus group. . Appl Environ Microbiol 75:, 6616–6618.[CrossRef]
    [Google Scholar]
  4. Balakrishnan I. , Baillod R.A. , Kibbler C.C. , Gillespie S.H. . ( 1997; ). Bacillus cereus peritonitis in a patient being treated with continuous ambulatory peritoneal dialysis. . Nephrol Dial Transplant 12:, 2447–2448.[CrossRef]
    [Google Scholar]
  5. Biasoli S. , Chiaramonte S. , Fabris A. , Feriani M. , Pisani F. , Ronco C. , Borin D. , Brendolan A. , La Greca G. . ( 1984; ). Bacillus cereus as agent of peritonitis during peritoneal dialysis. . Nephron 37:, 211–212.[CrossRef]
    [Google Scholar]
  6. Davenport A. . ( 2009; ). Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002‐2003. . Perit Dial Int 29:, 297–302.
    [Google Scholar]
  7. Gatselis N. , Malli E. , Papadamou G. , Petinaki E. , Dalekos G.N. . ( 2006; ). Direct detection of Cardiobacterium hominis in serum from a patient with infective endocarditis by broad‐range bacterial PCR. . J Clin Microbiol 44:, 669–672.[CrossRef]
    [Google Scholar]
  8. Goffin E. , Herbiet L. , Pouthier D. , Pochet J.M. , Lafontaine J.J. , Christophe J.L. , Gigi J. , Vandercam B. . ( 2004; ). Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis‐associated peritonitis. . Perit Dial Int 24:, 433–439.
    [Google Scholar]
  9. Lee Y.L. , Shih S.D. , Weng Y.J. , Chen C. , Liu C.E. . ( 2010; ). Fatal spontaneous bacterial peritonitis and necrotizing fasciitis with bacteraemia caused by Bacillus cereus in a patient with cirrhosis. . J Med Microbiol 59:, 242–244.[CrossRef]
    [Google Scholar]
  10. Li P.K. , Szeto C.C. , Piraino B. , Bernardini J. , Figueiredo A.E. , Gupta A. , Johnson D.W. , Kuijper E.J. , Lye W.C. , Salzer W. , Schaefer F. , Struijk D.G. . ( 2010; ). International Society for Peritoneal Dialysis. Peritoneal dialysis‐related infections recommendations: 2010 update. . Perit Dial Int 30:, 393–423.[CrossRef]
    [Google Scholar]
  11. Luna V.A. , King D.S. , Gulledge J. , Cannons A.C. , Amuso P.T. , Cattani J. . ( 2007; ). Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods. . J Antimicrob Chemother 60:, 555–567.[CrossRef]
    [Google Scholar]
  12. Monteverde M.L. , Sojo E.T. , Grosman M. , Hernandez C. , Delgado N. . ( 2006; ). Relapsing Bacillus cereus peritonitis in a pediatric patient on chronic peritoneal dialysis. . Perit Dial Int 26:, 715–716.
    [Google Scholar]
  13. Nessim S.J. , Nisenbaum R. , Bargman J.M. , Jassal S.V. . ( 2012; ). Microbiology of peritonitis in peritoneal dialysis patients with multiple episodes. . Perit Dial Int 32:, 316–321.[CrossRef]
    [Google Scholar]
  14. Nikitidou O. , Liakopoulos V. , Kiparissi T. , Divani M. , Leivaditis K. , Dombros N. . ( 2012; ). Peritoneal dialysis‐related infections recommendations: 2010 update. What is new?. . Int Urol Nephrol 44:, 593–600.[CrossRef]
    [Google Scholar]
  15. Odudu A. , Wilkie M. . ( 2011; ). Controversies in the management of infective complications of peritoneal dialysis. . Nephron Clin Pract 118:, c301–c308.[CrossRef]
    [Google Scholar]
  16. Pinedo S. , Bos A.J. , Siegert C.E.H. . ( 2002; ). Relapsing Bacillus cereus peritonitis in two patients on peritoneal dialysis. . Perit Dial Int 22:, 424–426.
    [Google Scholar]
  17. Ruiz S.R. , Reyes G.M. , Campos C.T. , Jimenez V.L. , Rojas R.T. , de la Fuente C.G. , Esteve A.A. . ( 2006; ). Relapsing Bacillus cereus peritonitis during automated peritoneal dialysis. . Perit Dial Int 26:, 612–613.
    [Google Scholar]
  18. Savini V. , Favaro M. , Fontana C. , Catavitello C. , Balbinot A. , Talia M. , Febbo F. , D’Antonio D. . ( 2009; ). Bacillus cereus heteroresistance to carbapenems in a cancer patient. . J Hosp Infect 71:, 288–290.[CrossRef]
    [Google Scholar]
  19. Turnbull P.C. , Sirianni N.M. , LeBron C.I. , Samaan M.N. , Sutton F.N. , Reyes A.E. , Peruski L.F. Jr . ( 2004; ). MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest. . J Clin Microbiol 42:, 3626–3634.[CrossRef]
    [Google Scholar]
  20. Uchino Y. , Iriyama N. , Matsumoto K. , Hirabayashi Y. , Miura K. , Kurita D. , Kobayashi Y. , Yagi M. , Kodaira H. . other authors. ( 2012; ). A case series of Bacillus cereus septicemia in patients with hematological disease. . Intern Med 51:, 2733–2738.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.003400
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.003400
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error